id	sid	tid	token	lemma	pos
work_xuhc2rtekzcknbwcjbro6xyloi	1	1	HP6	hp6	NN
work_xuhc2rtekzcknbwcjbro6xyloi	1	2	RELATIONSHIP	RELATIONSHIP	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	1	3	OF	of	IN
work_xuhc2rtekzcknbwcjbro6xyloi	1	4	DIRECT	direct	NN
work_xuhc2rtekzcknbwcjbro6xyloi	1	5	-	-	HYPH
work_xuhc2rtekzcknbwcjbro6xyloi	1	6	TO	to	IN
work_xuhc2rtekzcknbwcjbro6xyloi	1	7	-	-	HYPH
work_xuhc2rtekzcknbwcjbro6xyloi	1	8	CONSUMER	consumer	NN
work_xuhc2rtekzcknbwcjbro6xyloi	1	9	ADVERTISING	advertising	NN
work_xuhc2rtekzcknbwcjbro6xyloi	1	10	SPENDING	spending	NN
work_xuhc2rtekzcknbwcjbro6xyloi	1	11	AND	and	CC
work_xuhc2rtekzcknbwcjbro6xyloi	1	12	DRUG	drug	NN
work_xuhc2rtekzcknbwcjbro6xyloi	1	13	PRICING	pricing	NN
work_xuhc2rtekzcknbwcjbro6xyloi	1	14	FOR	for	IN
work_xuhc2rtekzcknbwcjbro6xyloi	1	15	THE	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	1	16	TOP	top	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	1	17	TWENTY	TWENTY	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	1	18	DRUGS	drugs	NN
work_xuhc2rtekzcknbwcjbro6xyloi	1	19	FROM	from	IN
work_xuhc2rtekzcknbwcjbro6xyloi	1	20	1997	1997	CD
work_xuhc2rtekzcknbwcjbro6xyloi	1	21	TO	to	IN
work_xuhc2rtekzcknbwcjbro6xyloi	1	22	2000	2000	CD
work_xuhc2rtekzcknbwcjbro6xyloi	1	23	:	:	:
work_xuhc2rtekzcknbwcjbro6xyloi	1	24	AN	an	DT
work_xuhc2rtekzcknbwcjbro6xyloi	1	25	EXPLORATORY	EXPLORATORY	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	1	26	STUDY	STUDY	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	1	27	133Abstracts	133abstract	VBZ
work_xuhc2rtekzcknbwcjbro6xyloi	1	28	medication	medication	NN
work_xuhc2rtekzcknbwcjbro6xyloi	1	29	(	(	-LRB-
work_xuhc2rtekzcknbwcjbro6xyloi	1	30	p	p	NN
work_xuhc2rtekzcknbwcjbro6xyloi	1	31	=	=	SYM
work_xuhc2rtekzcknbwcjbro6xyloi	1	32	0.017	0.017	CD
work_xuhc2rtekzcknbwcjbro6xyloi	1	33	)	)	-RRB-
work_xuhc2rtekzcknbwcjbro6xyloi	1	34	;	;	:
work_xuhc2rtekzcknbwcjbro6xyloi	1	35	more	more	RBR
work_xuhc2rtekzcknbwcjbro6xyloi	1	36	likely	likely	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	1	37	to	to	TO
work_xuhc2rtekzcknbwcjbro6xyloi	1	38	become	become	VB
work_xuhc2rtekzcknbwcjbro6xyloi	1	39	frustrated	frustrated	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	1	40	(	(	-LRB-
work_xuhc2rtekzcknbwcjbro6xyloi	1	41	p	p	NN
work_xuhc2rtekzcknbwcjbro6xyloi	1	42	=	=	SYM
work_xuhc2rtekzcknbwcjbro6xyloi	1	43	0.003	0.003	CD
work_xuhc2rtekzcknbwcjbro6xyloi	1	44	)	)	-RRB-
work_xuhc2rtekzcknbwcjbro6xyloi	1	45	and	and	CC
work_xuhc2rtekzcknbwcjbro6xyloi	1	46	annoyed	annoy	VBN
work_xuhc2rtekzcknbwcjbro6xyloi	1	47	(	(	-LRB-
work_xuhc2rtekzcknbwcjbro6xyloi	1	48	p	p	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	1	49	<	<	XX
work_xuhc2rtekzcknbwcjbro6xyloi	1	50	0.001	0.001	CD
work_xuhc2rtekzcknbwcjbro6xyloi	1	51	)	)	-RRB-
work_xuhc2rtekzcknbwcjbro6xyloi	1	52	with	with	IN
work_xuhc2rtekzcknbwcjbro6xyloi	1	53	the	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	1	54	patient	patient	NN
work_xuhc2rtekzcknbwcjbro6xyloi	1	55	for	for	IN
work_xuhc2rtekzcknbwcjbro6xyloi	1	56	asking	ask	VBG
work_xuhc2rtekzcknbwcjbro6xyloi	1	57	to	to	TO
work_xuhc2rtekzcknbwcjbro6xyloi	1	58	try	try	VB
work_xuhc2rtekzcknbwcjbro6xyloi	1	59	a	a	DT
work_xuhc2rtekzcknbwcjbro6xyloi	1	60	medication	medication	NN
work_xuhc2rtekzcknbwcjbro6xyloi	1	61	;	;	:
work_xuhc2rtekzcknbwcjbro6xyloi	1	62	and	and	CC
work_xuhc2rtekzcknbwcjbro6xyloi	1	63	less	less	RBR
work_xuhc2rtekzcknbwcjbro6xyloi	1	64	likely	likely	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	1	65	to	to	TO
work_xuhc2rtekzcknbwcjbro6xyloi	1	66	provide	provide	VB
work_xuhc2rtekzcknbwcjbro6xyloi	1	67	samples	sample	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	1	68	(	(	-LRB-
work_xuhc2rtekzcknbwcjbro6xyloi	1	69	p	p	NN
work_xuhc2rtekzcknbwcjbro6xyloi	1	70	=	=	SYM
work_xuhc2rtekzcknbwcjbro6xyloi	1	71	0.001	0.001	CD
work_xuhc2rtekzcknbwcjbro6xyloi	1	72	)	)	-RRB-
work_xuhc2rtekzcknbwcjbro6xyloi	1	73	or	or	CC
work_xuhc2rtekzcknbwcjbro6xyloi	1	74	a	a	DT
work_xuhc2rtekzcknbwcjbro6xyloi	1	75	prescription	prescription	NN
work_xuhc2rtekzcknbwcjbro6xyloi	1	76	(	(	-LRB-
work_xuhc2rtekzcknbwcjbro6xyloi	1	77	p	p	NN
work_xuhc2rtekzcknbwcjbro6xyloi	1	78	<	<	XX
work_xuhc2rtekzcknbwcjbro6xyloi	1	79	0.001	0.001	CD
work_xuhc2rtekzcknbwcjbro6xyloi	1	80	)	)	-RRB-
work_xuhc2rtekzcknbwcjbro6xyloi	1	81	for	for	IN
work_xuhc2rtekzcknbwcjbro6xyloi	1	82	a	a	DT
work_xuhc2rtekzcknbwcjbro6xyloi	1	83	medication	medication	NN
work_xuhc2rtekzcknbwcjbro6xyloi	1	84	.	.	.
work_xuhc2rtekzcknbwcjbro6xyloi	2	1	CONCLUSION	conclusion	NN
work_xuhc2rtekzcknbwcjbro6xyloi	2	2	:	:	:
work_xuhc2rtekzcknbwcjbro6xyloi	2	3	Clinicians	clinician	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	2	4	are	be	VBP
work_xuhc2rtekzcknbwcjbro6xyloi	2	5	amenable	amenable	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	2	6	to	to	IN
work_xuhc2rtekzcknbwcjbro6xyloi	2	7	patients	patient	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	2	8	asking	ask	VBG
work_xuhc2rtekzcknbwcjbro6xyloi	2	9	for	for	IN
work_xuhc2rtekzcknbwcjbro6xyloi	2	10	drug	drug	NN
work_xuhc2rtekzcknbwcjbro6xyloi	2	11	information	information	NN
work_xuhc2rtekzcknbwcjbro6xyloi	2	12	and	and	CC
work_xuhc2rtekzcknbwcjbro6xyloi	2	13	medications	medication	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	2	14	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	2	15	but	but	CC
work_xuhc2rtekzcknbwcjbro6xyloi	2	16	their	-PRON-	PRP$
work_xuhc2rtekzcknbwcjbro6xyloi	2	17	level	level	NN
work_xuhc2rtekzcknbwcjbro6xyloi	2	18	of	of	IN
work_xuhc2rtekzcknbwcjbro6xyloi	2	19	receptiveness	receptiveness	NN
work_xuhc2rtekzcknbwcjbro6xyloi	2	20	is	be	VBZ
work_xuhc2rtekzcknbwcjbro6xyloi	2	21	associated	associate	VBN
work_xuhc2rtekzcknbwcjbro6xyloi	2	22	with	with	IN
work_xuhc2rtekzcknbwcjbro6xyloi	2	23	the	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	2	24	source	source	NN
work_xuhc2rtekzcknbwcjbro6xyloi	2	25	from	from	IN
work_xuhc2rtekzcknbwcjbro6xyloi	2	26	which	which	WDT
work_xuhc2rtekzcknbwcjbro6xyloi	2	27	the	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	2	28	patient	patient	NN
work_xuhc2rtekzcknbwcjbro6xyloi	2	29	’s	’s	POS
work_xuhc2rtekzcknbwcjbro6xyloi	2	30	questions	question	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	2	31	originate	originate	VBP
work_xuhc2rtekzcknbwcjbro6xyloi	2	32	.	.	.
work_xuhc2rtekzcknbwcjbro6xyloi	3	1	HP6	hp6	NN
work_xuhc2rtekzcknbwcjbro6xyloi	3	2	RELATIONSHIP	RELATIONSHIP	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	3	3	OF	of	IN
work_xuhc2rtekzcknbwcjbro6xyloi	3	4	DIRECT	direct	NN
work_xuhc2rtekzcknbwcjbro6xyloi	3	5	-	-	HYPH
work_xuhc2rtekzcknbwcjbro6xyloi	3	6	TO	to	IN
work_xuhc2rtekzcknbwcjbro6xyloi	3	7	-	-	HYPH
work_xuhc2rtekzcknbwcjbro6xyloi	3	8	CONSUMER	consumer	NN
work_xuhc2rtekzcknbwcjbro6xyloi	3	9	ADVERTISING	advertising	NN
work_xuhc2rtekzcknbwcjbro6xyloi	3	10	SPENDING	spending	NN
work_xuhc2rtekzcknbwcjbro6xyloi	3	11	AND	and	CC
work_xuhc2rtekzcknbwcjbro6xyloi	3	12	DRUG	drug	NN
work_xuhc2rtekzcknbwcjbro6xyloi	3	13	PRICING	pricing	NN
work_xuhc2rtekzcknbwcjbro6xyloi	3	14	FOR	for	IN
work_xuhc2rtekzcknbwcjbro6xyloi	3	15	THE	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	3	16	TOP	top	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	3	17	TWENTY	TWENTY	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	3	18	DRUGS	drugs	NN
work_xuhc2rtekzcknbwcjbro6xyloi	3	19	FROM	from	IN
work_xuhc2rtekzcknbwcjbro6xyloi	3	20	1997	1997	CD
work_xuhc2rtekzcknbwcjbro6xyloi	3	21	TO	to	IN
work_xuhc2rtekzcknbwcjbro6xyloi	3	22	2000	2000	CD
work_xuhc2rtekzcknbwcjbro6xyloi	3	23	:	:	:
work_xuhc2rtekzcknbwcjbro6xyloi	3	24	AN	an	DT
work_xuhc2rtekzcknbwcjbro6xyloi	3	25	EXPLORATORY	EXPLORATORY	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	3	26	STUDY	STUDY	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	3	27	Parthan	Parthan	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	3	28	AG	AG	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	3	29	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	3	30	Anantharaman	Anantharaman	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	3	31	RT	RT	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	3	32	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	3	33	Shepherd	Shepherd	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	3	34	MD	MD	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	3	35	The	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	3	36	University	University	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	3	37	of	of	IN
work_xuhc2rtekzcknbwcjbro6xyloi	3	38	Texas	Texas	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	3	39	at	at	IN
work_xuhc2rtekzcknbwcjbro6xyloi	3	40	Austin	Austin	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	3	41	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	3	42	Austin	Austin	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	3	43	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	3	44	TX	TX	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	3	45	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	3	46	USA	USA	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	3	47	There	there	EX
work_xuhc2rtekzcknbwcjbro6xyloi	3	48	exists	exist	VBZ
work_xuhc2rtekzcknbwcjbro6xyloi	3	49	an	an	DT
work_xuhc2rtekzcknbwcjbro6xyloi	3	50	ongoing	ongoing	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	3	51	debate	debate	NN
work_xuhc2rtekzcknbwcjbro6xyloi	3	52	regarding	regard	VBG
work_xuhc2rtekzcknbwcjbro6xyloi	3	53	the	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	3	54	effect	effect	NN
work_xuhc2rtekzcknbwcjbro6xyloi	3	55	of	of	IN
work_xuhc2rtekzcknbwcjbro6xyloi	3	56	direct	direct	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	3	57	-	-	HYPH
work_xuhc2rtekzcknbwcjbro6xyloi	3	58	to	to	IN
work_xuhc2rtekzcknbwcjbro6xyloi	3	59	-	-	HYPH
work_xuhc2rtekzcknbwcjbro6xyloi	3	60	consumer	consumer	NN
work_xuhc2rtekzcknbwcjbro6xyloi	3	61	(	(	-LRB-
work_xuhc2rtekzcknbwcjbro6xyloi	3	62	DTC	DTC	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	3	63	)	)	-RRB-
work_xuhc2rtekzcknbwcjbro6xyloi	3	64	advertising	advertising	NN
work_xuhc2rtekzcknbwcjbro6xyloi	3	65	spending	spending	NN
work_xuhc2rtekzcknbwcjbro6xyloi	3	66	on	on	IN
work_xuhc2rtekzcknbwcjbro6xyloi	3	67	drug	drug	NN
work_xuhc2rtekzcknbwcjbro6xyloi	3	68	prices	price	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	3	69	.	.	.
work_xuhc2rtekzcknbwcjbro6xyloi	4	1	The	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	4	2	two	two	CD
work_xuhc2rtekzcknbwcjbro6xyloi	4	3	opposite	opposite	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	4	4	views	view	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	4	5	are	be	VBP
work_xuhc2rtekzcknbwcjbro6xyloi	4	6	:	:	:
work_xuhc2rtekzcknbwcjbro6xyloi	4	7	(	(	-LRB-
work_xuhc2rtekzcknbwcjbro6xyloi	4	8	a	a	LS
work_xuhc2rtekzcknbwcjbro6xyloi	4	9	)	)	-RRB-
work_xuhc2rtekzcknbwcjbro6xyloi	4	10	increase	increase	NN
work_xuhc2rtekzcknbwcjbro6xyloi	4	11	in	in	IN
work_xuhc2rtekzcknbwcjbro6xyloi	4	12	DTC	dtc	NN
work_xuhc2rtekzcknbwcjbro6xyloi	4	13	advertising	advertising	NN
work_xuhc2rtekzcknbwcjbro6xyloi	4	14	spending	spending	NN
work_xuhc2rtekzcknbwcjbro6xyloi	4	15	would	would	MD
work_xuhc2rtekzcknbwcjbro6xyloi	4	16	be	be	VB
work_xuhc2rtekzcknbwcjbro6xyloi	4	17	added	add	VBN
work_xuhc2rtekzcknbwcjbro6xyloi	4	18	to	to	IN
work_xuhc2rtekzcknbwcjbro6xyloi	4	19	drug	drug	NN
work_xuhc2rtekzcknbwcjbro6xyloi	4	20	prices	price	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	4	21	(	(	-LRB-
work_xuhc2rtekzcknbwcjbro6xyloi	4	22	b	b	LS
work_xuhc2rtekzcknbwcjbro6xyloi	4	23	)	)	-RRB-
work_xuhc2rtekzcknbwcjbro6xyloi	4	24	DTC	dtc	NN
work_xuhc2rtekzcknbwcjbro6xyloi	4	25	advertising	advertising	NN
work_xuhc2rtekzcknbwcjbro6xyloi	4	26	would	would	MD
work_xuhc2rtekzcknbwcjbro6xyloi	4	27	increase	increase	VB
work_xuhc2rtekzcknbwcjbro6xyloi	4	28	competition	competition	NN
work_xuhc2rtekzcknbwcjbro6xyloi	4	29	and	and	CC
work_xuhc2rtekzcknbwcjbro6xyloi	4	30	thus	thus	RB
work_xuhc2rtekzcknbwcjbro6xyloi	4	31	reduce	reduce	VB
work_xuhc2rtekzcknbwcjbro6xyloi	4	32	drug	drug	NN
work_xuhc2rtekzcknbwcjbro6xyloi	4	33	prices	price	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	4	34	.	.	.
work_xuhc2rtekzcknbwcjbro6xyloi	5	1	OBJECTIVE	objective	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	5	2	:	:	:
work_xuhc2rtekzcknbwcjbro6xyloi	5	3	Explore	explore	VB
work_xuhc2rtekzcknbwcjbro6xyloi	5	4	the	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	5	5	relationship	relationship	NN
work_xuhc2rtekzcknbwcjbro6xyloi	5	6	of	of	IN
work_xuhc2rtekzcknbwcjbro6xyloi	5	7	DTC	DTC	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	5	8	advertis-	advertis-	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	5	9	ing	ing	NN
work_xuhc2rtekzcknbwcjbro6xyloi	5	10	spending	spending	NN
work_xuhc2rtekzcknbwcjbro6xyloi	5	11	and	and	CC
work_xuhc2rtekzcknbwcjbro6xyloi	5	12	drug	drug	NN
work_xuhc2rtekzcknbwcjbro6xyloi	5	13	pricing	pricing	NN
work_xuhc2rtekzcknbwcjbro6xyloi	5	14	for	for	IN
work_xuhc2rtekzcknbwcjbro6xyloi	5	15	the	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	5	16	top	top	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	5	17	twenty	twenty	CD
work_xuhc2rtekzcknbwcjbro6xyloi	5	18	drugs	drug	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	5	19	from	from	IN
work_xuhc2rtekzcknbwcjbro6xyloi	5	20	1997	1997	CD
work_xuhc2rtekzcknbwcjbro6xyloi	5	21	to	to	IN
work_xuhc2rtekzcknbwcjbro6xyloi	5	22	2000	2000	CD
work_xuhc2rtekzcknbwcjbro6xyloi	5	23	.	.	.
work_xuhc2rtekzcknbwcjbro6xyloi	6	1	METHODS	methods	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	6	2	:	:	:
work_xuhc2rtekzcknbwcjbro6xyloi	6	3	Top	top	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	6	4	twenty	twenty	CD
work_xuhc2rtekzcknbwcjbro6xyloi	6	5	drugs	drug	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	6	6	were	be	VBD
work_xuhc2rtekzcknbwcjbro6xyloi	6	7	selected	select	VBN
work_xuhc2rtekzcknbwcjbro6xyloi	6	8	on	on	IN
work_xuhc2rtekzcknbwcjbro6xyloi	6	9	the	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	6	10	basis	basis	NN
work_xuhc2rtekzcknbwcjbro6xyloi	6	11	of	of	IN
work_xuhc2rtekzcknbwcjbro6xyloi	6	12	their	-PRON-	PRP$
work_xuhc2rtekzcknbwcjbro6xyloi	6	13	DTC	dtc	NN
work_xuhc2rtekzcknbwcjbro6xyloi	6	14	advertising	advertising	NN
work_xuhc2rtekzcknbwcjbro6xyloi	6	15	spending	spending	NN
work_xuhc2rtekzcknbwcjbro6xyloi	6	16	(	(	-LRB-
work_xuhc2rtekzcknbwcjbro6xyloi	6	17	source	source	NN
work_xuhc2rtekzcknbwcjbro6xyloi	6	18	:	:	:
work_xuhc2rtekzcknbwcjbro6xyloi	6	19	Competitive	competitive	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	6	20	Media	Media	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	6	21	Reporting	Reporting	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	6	22	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	6	23	NY	NY	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	6	24	)	)	-RRB-
work_xuhc2rtekzcknbwcjbro6xyloi	6	25	for	for	IN
work_xuhc2rtekzcknbwcjbro6xyloi	6	26	1997	1997	CD
work_xuhc2rtekzcknbwcjbro6xyloi	6	27	.	.	.
work_xuhc2rtekzcknbwcjbro6xyloi	7	1	For	for	IN
work_xuhc2rtekzcknbwcjbro6xyloi	7	2	analysis	analysis	NN
work_xuhc2rtekzcknbwcjbro6xyloi	7	3	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	7	4	average	average	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	7	5	wholesale	wholesale	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	7	6	price	price	NN
work_xuhc2rtekzcknbwcjbro6xyloi	7	7	(	(	-LRB-
work_xuhc2rtekzcknbwcjbro6xyloi	7	8	AWP	AWP	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	7	9	)	)	-RRB-
work_xuhc2rtekzcknbwcjbro6xyloi	7	10	per	per	IN
work_xuhc2rtekzcknbwcjbro6xyloi	7	11	unit	unit	NN
work_xuhc2rtekzcknbwcjbro6xyloi	7	12	was	be	VBD
work_xuhc2rtekzcknbwcjbro6xyloi	7	13	used	use	VBN
work_xuhc2rtekzcknbwcjbro6xyloi	7	14	from	from	IN
work_xuhc2rtekzcknbwcjbro6xyloi	7	15	the	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	7	16	Blue	Blue	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	7	17	Book	Book	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	7	18	AWP	AWP	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	7	19	Unit	Unit	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	7	20	pricing	pricing	NN
work_xuhc2rtekzcknbwcjbro6xyloi	7	21	.	.	.
work_xuhc2rtekzcknbwcjbro6xyloi	8	1	For	for	IN
work_xuhc2rtekzcknbwcjbro6xyloi	8	2	each	each	DT
work_xuhc2rtekzcknbwcjbro6xyloi	8	3	of	of	IN
work_xuhc2rtekzcknbwcjbro6xyloi	8	4	the	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	8	5	top	top	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	8	6	twenty	twenty	CD
work_xuhc2rtekzcknbwcjbro6xyloi	8	7	drugs	drug	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	8	8	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	8	9	the	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	8	10	following	follow	VBG
work_xuhc2rtekzcknbwcjbro6xyloi	8	11	trend	trend	NN
work_xuhc2rtekzcknbwcjbro6xyloi	8	12	graphs	graph	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	8	13	were	be	VBD
work_xuhc2rtekzcknbwcjbro6xyloi	8	14	plotted	plot	VBN
work_xuhc2rtekzcknbwcjbro6xyloi	8	15	for	for	IN
work_xuhc2rtekzcknbwcjbro6xyloi	8	16	1997	1997	CD
work_xuhc2rtekzcknbwcjbro6xyloi	8	17	to	to	IN
work_xuhc2rtekzcknbwcjbro6xyloi	8	18	2000	2000	CD
work_xuhc2rtekzcknbwcjbro6xyloi	8	19	:	:	:
work_xuhc2rtekzcknbwcjbro6xyloi	8	20	(	(	-LRB-
work_xuhc2rtekzcknbwcjbro6xyloi	8	21	a	a	LS
work_xuhc2rtekzcknbwcjbro6xyloi	8	22	)	)	-RRB-
work_xuhc2rtekzcknbwcjbro6xyloi	8	23	the	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	8	24	total	total	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	8	25	DTC	DTC	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	8	26	advertising	advertising	NN
work_xuhc2rtekzcknbwcjbro6xyloi	8	27	spending	spending	NN
work_xuhc2rtekzcknbwcjbro6xyloi	8	28	and	and	CC
work_xuhc2rtekzcknbwcjbro6xyloi	8	29	per	per	IN
work_xuhc2rtekzcknbwcjbro6xyloi	8	30	unit	unit	NN
work_xuhc2rtekzcknbwcjbro6xyloi	8	31	price	price	NN
work_xuhc2rtekzcknbwcjbro6xyloi	8	32	of	of	IN
work_xuhc2rtekzcknbwcjbro6xyloi	8	33	the	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	8	34	drug	drug	NN
work_xuhc2rtekzcknbwcjbro6xyloi	8	35	;	;	:
work_xuhc2rtekzcknbwcjbro6xyloi	8	36	(	(	-LRB-
work_xuhc2rtekzcknbwcjbro6xyloi	8	37	b	b	LS
work_xuhc2rtekzcknbwcjbro6xyloi	8	38	)	)	-RRB-
work_xuhc2rtekzcknbwcjbro6xyloi	8	39	the	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	8	40	percent	percent	NN
work_xuhc2rtekzcknbwcjbro6xyloi	8	41	changes	change	VBZ
work_xuhc2rtekzcknbwcjbro6xyloi	8	42	in	in	IN
work_xuhc2rtekzcknbwcjbro6xyloi	8	43	the	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	8	44	DTC	DTC	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	8	45	advertis-	advertis-	NN
work_xuhc2rtekzcknbwcjbro6xyloi	8	46	ing	ing	NN
work_xuhc2rtekzcknbwcjbro6xyloi	8	47	spending	spending	NN
work_xuhc2rtekzcknbwcjbro6xyloi	8	48	and	and	CC
work_xuhc2rtekzcknbwcjbro6xyloi	8	49	drug	drug	NN
work_xuhc2rtekzcknbwcjbro6xyloi	8	50	price	price	NN
work_xuhc2rtekzcknbwcjbro6xyloi	8	51	.	.	.
work_xuhc2rtekzcknbwcjbro6xyloi	9	1	The	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	9	2	percent	percent	NN
work_xuhc2rtekzcknbwcjbro6xyloi	9	3	change	change	NN
work_xuhc2rtekzcknbwcjbro6xyloi	9	4	in	in	IN
work_xuhc2rtekzcknbwcjbro6xyloi	9	5	DTC	DTC	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	9	6	advertising	advertising	NN
work_xuhc2rtekzcknbwcjbro6xyloi	9	7	spending	spending	NN
work_xuhc2rtekzcknbwcjbro6xyloi	9	8	and	and	CC
work_xuhc2rtekzcknbwcjbro6xyloi	9	9	drug	drug	NN
work_xuhc2rtekzcknbwcjbro6xyloi	9	10	price	price	NN
work_xuhc2rtekzcknbwcjbro6xyloi	9	11	for	for	IN
work_xuhc2rtekzcknbwcjbro6xyloi	9	12	a	a	DT
work_xuhc2rtekzcknbwcjbro6xyloi	9	13	year	year	NN
work_xuhc2rtekzcknbwcjbro6xyloi	9	14	was	be	VBD
work_xuhc2rtekzcknbwcjbro6xyloi	9	15	calculated	calculate	VBN
work_xuhc2rtekzcknbwcjbro6xyloi	9	16	as	as	IN
work_xuhc2rtekzcknbwcjbro6xyloi	9	17	percent	percent	NN
work_xuhc2rtekzcknbwcjbro6xyloi	9	18	change	change	NN
work_xuhc2rtekzcknbwcjbro6xyloi	9	19	from	from	IN
work_xuhc2rtekzcknbwcjbro6xyloi	9	20	the	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	9	21	previous	previous	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	9	22	year	year	NN
work_xuhc2rtekzcknbwcjbro6xyloi	9	23	.	.	.
work_xuhc2rtekzcknbwcjbro6xyloi	10	1	RESULTS	RESULTS	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	10	2	:	:	:
work_xuhc2rtekzcknbwcjbro6xyloi	10	3	Only	only	RB
work_xuhc2rtekzcknbwcjbro6xyloi	10	4	sildenafil	sildenafil	NN
work_xuhc2rtekzcknbwcjbro6xyloi	10	5	(	(	-LRB-
work_xuhc2rtekzcknbwcjbro6xyloi	10	6	Viagra	Viagra	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	10	7	)	)	-RRB-
work_xuhc2rtekzcknbwcjbro6xyloi	10	8	and	and	CC
work_xuhc2rtekzcknbwcjbro6xyloi	10	9	sibutramine	sibutramine	VB
work_xuhc2rtekzcknbwcjbro6xyloi	10	10	(	(	-LRB-
work_xuhc2rtekzcknbwcjbro6xyloi	10	11	Meridia	Meridia	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	10	12	)	)	-RRB-
work_xuhc2rtekzcknbwcjbro6xyloi	10	13	showed	show	VBD
work_xuhc2rtekzcknbwcjbro6xyloi	10	14	an	an	DT
work_xuhc2rtekzcknbwcjbro6xyloi	10	15	increase	increase	NN
work_xuhc2rtekzcknbwcjbro6xyloi	10	16	in	in	IN
work_xuhc2rtekzcknbwcjbro6xyloi	10	17	the	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	10	18	actual	actual	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	10	19	drug	drug	NN
work_xuhc2rtekzcknbwcjbro6xyloi	10	20	price	price	NN
work_xuhc2rtekzcknbwcjbro6xyloi	10	21	with	with	IN
work_xuhc2rtekzcknbwcjbro6xyloi	10	22	an	an	DT
work_xuhc2rtekzcknbwcjbro6xyloi	10	23	increase	increase	NN
work_xuhc2rtekzcknbwcjbro6xyloi	10	24	in	in	IN
work_xuhc2rtekzcknbwcjbro6xyloi	10	25	the	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	10	26	DTC	dtc	NN
work_xuhc2rtekzcknbwcjbro6xyloi	10	27	advertising	advertising	NN
work_xuhc2rtekzcknbwcjbro6xyloi	10	28	spending	spending	NN
work_xuhc2rtekzcknbwcjbro6xyloi	10	29	.	.	.
work_xuhc2rtekzcknbwcjbro6xyloi	11	1	However	however	RB
work_xuhc2rtekzcknbwcjbro6xyloi	11	2	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	11	3	for	for	IN
work_xuhc2rtekzcknbwcjbro6xyloi	11	4	these	these	DT
work_xuhc2rtekzcknbwcjbro6xyloi	11	5	two	two	CD
work_xuhc2rtekzcknbwcjbro6xyloi	11	6	drugs	drug	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	11	7	in	in	IN
work_xuhc2rtekzcknbwcjbro6xyloi	11	8	year	year	NN
work_xuhc2rtekzcknbwcjbro6xyloi	11	9	2000	2000	CD
work_xuhc2rtekzcknbwcjbro6xyloi	11	10	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	11	11	the	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	11	12	percent	percent	NN
work_xuhc2rtekzcknbwcjbro6xyloi	11	13	change	change	NN
work_xuhc2rtekzcknbwcjbro6xyloi	11	14	in	in	IN
work_xuhc2rtekzcknbwcjbro6xyloi	11	15	DTC	DTC	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	11	16	advertising	advertising	NN
work_xuhc2rtekzcknbwcjbro6xyloi	11	17	spending	spending	NN
work_xuhc2rtekzcknbwcjbro6xyloi	11	18	decreased	decrease	VBD
work_xuhc2rtekzcknbwcjbro6xyloi	11	19	and	and	CC
work_xuhc2rtekzcknbwcjbro6xyloi	11	20	the	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	11	21	percent	percent	NN
work_xuhc2rtekzcknbwcjbro6xyloi	11	22	change	change	NN
work_xuhc2rtekzcknbwcjbro6xyloi	11	23	in	in	IN
work_xuhc2rtekzcknbwcjbro6xyloi	11	24	drug	drug	NN
work_xuhc2rtekzcknbwcjbro6xyloi	11	25	price	price	NN
work_xuhc2rtekzcknbwcjbro6xyloi	11	26	increased	increase	VBD
work_xuhc2rtekzcknbwcjbro6xyloi	11	27	.	.	.
work_xuhc2rtekzcknbwcjbro6xyloi	12	1	No	no	DT
work_xuhc2rtekzcknbwcjbro6xyloi	12	2	trend	trend	NN
work_xuhc2rtekzcknbwcjbro6xyloi	12	3	was	be	VBD
work_xuhc2rtekzcknbwcjbro6xyloi	12	4	evident	evident	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	12	5	from	from	IN
work_xuhc2rtekzcknbwcjbro6xyloi	12	6	the	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	12	7	graphs	graphs	NN
work_xuhc2rtekzcknbwcjbro6xyloi	12	8	of	of	IN
work_xuhc2rtekzcknbwcjbro6xyloi	12	9	the	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	12	10	other	other	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	12	11	eighteen	eighteen	CD
work_xuhc2rtekzcknbwcjbro6xyloi	12	12	drugs	drug	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	12	13	.	.	.
work_xuhc2rtekzcknbwcjbro6xyloi	13	1	On	on	IN
work_xuhc2rtekzcknbwcjbro6xyloi	13	2	an	an	DT
work_xuhc2rtekzcknbwcjbro6xyloi	13	3	average	average	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	13	4	DTC	dtc	NN
work_xuhc2rtekzcknbwcjbro6xyloi	13	5	advertising	advertising	NN
work_xuhc2rtekzcknbwcjbro6xyloi	13	6	spending	spending	NN
work_xuhc2rtekzcknbwcjbro6xyloi	13	7	for	for	IN
work_xuhc2rtekzcknbwcjbro6xyloi	13	8	most	most	JJS
work_xuhc2rtekzcknbwcjbro6xyloi	13	9	of	of	IN
work_xuhc2rtekzcknbwcjbro6xyloi	13	10	the	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	13	11	drugs	drug	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	13	12	decreased	decrease	VBD
work_xuhc2rtekzcknbwcjbro6xyloi	13	13	with	with	IN
work_xuhc2rtekzcknbwcjbro6xyloi	13	14	time	time	NN
work_xuhc2rtekzcknbwcjbro6xyloi	13	15	while	while	IN
work_xuhc2rtekzcknbwcjbro6xyloi	13	16	drug	drug	NN
work_xuhc2rtekzcknbwcjbro6xyloi	13	17	prices	price	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	13	18	continued	continue	VBD
work_xuhc2rtekzcknbwcjbro6xyloi	13	19	to	to	TO
work_xuhc2rtekzcknbwcjbro6xyloi	13	20	increase	increase	VB
work_xuhc2rtekzcknbwcjbro6xyloi	13	21	.	.	.
work_xuhc2rtekzcknbwcjbro6xyloi	14	1	CONCLUSION	conclusion	NN
work_xuhc2rtekzcknbwcjbro6xyloi	14	2	:	:	:
work_xuhc2rtekzcknbwcjbro6xyloi	14	3	Results	result	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	14	4	indicate	indicate	VBP
work_xuhc2rtekzcknbwcjbro6xyloi	14	5	a	a	DT
work_xuhc2rtekzcknbwcjbro6xyloi	14	6	very	very	RB
work_xuhc2rtekzcknbwcjbro6xyloi	14	7	weak	weak	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	14	8	relation-	relation-	NN
work_xuhc2rtekzcknbwcjbro6xyloi	14	9	ship	ship	NN
work_xuhc2rtekzcknbwcjbro6xyloi	14	10	between	between	IN
work_xuhc2rtekzcknbwcjbro6xyloi	14	11	DTC	DTC	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	14	12	advertising	advertising	NN
work_xuhc2rtekzcknbwcjbro6xyloi	14	13	spending	spending	NN
work_xuhc2rtekzcknbwcjbro6xyloi	14	14	and	and	CC
work_xuhc2rtekzcknbwcjbro6xyloi	14	15	drug	drug	NN
work_xuhc2rtekzcknbwcjbro6xyloi	14	16	prices	price	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	14	17	.	.	.
work_xuhc2rtekzcknbwcjbro6xyloi	15	1	The	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	15	2	increase	increase	NN
work_xuhc2rtekzcknbwcjbro6xyloi	15	3	in	in	IN
work_xuhc2rtekzcknbwcjbro6xyloi	15	4	drug	drug	NN
work_xuhc2rtekzcknbwcjbro6xyloi	15	5	price	price	NN
work_xuhc2rtekzcknbwcjbro6xyloi	15	6	in	in	IN
work_xuhc2rtekzcknbwcjbro6xyloi	15	7	spite	spite	NN
work_xuhc2rtekzcknbwcjbro6xyloi	15	8	of	of	IN
work_xuhc2rtekzcknbwcjbro6xyloi	15	9	the	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	15	10	decrease	decrease	NN
work_xuhc2rtekzcknbwcjbro6xyloi	15	11	in	in	IN
work_xuhc2rtekzcknbwcjbro6xyloi	15	12	the	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	15	13	DTC	DTC	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	15	14	advertising	advertising	NN
work_xuhc2rtekzcknbwcjbro6xyloi	15	15	spending	spending	NN
work_xuhc2rtekzcknbwcjbro6xyloi	15	16	contradicts	contradict	VBZ
work_xuhc2rtekzcknbwcjbro6xyloi	15	17	both	both	CC
work_xuhc2rtekzcknbwcjbro6xyloi	15	18	rationale	rationale	NN
work_xuhc2rtekzcknbwcjbro6xyloi	15	19	i.e.	i.e.	FW
work_xuhc2rtekzcknbwcjbro6xyloi	16	1	DTC	dtc	NN
work_xuhc2rtekzcknbwcjbro6xyloi	16	2	advertising	advertising	NN
work_xuhc2rtekzcknbwcjbro6xyloi	16	3	spending	spending	NN
work_xuhc2rtekzcknbwcjbro6xyloi	16	4	reduces	reduce	VBZ
work_xuhc2rtekzcknbwcjbro6xyloi	16	5	drug	drug	NN
work_xuhc2rtekzcknbwcjbro6xyloi	16	6	price	price	NN
work_xuhc2rtekzcknbwcjbro6xyloi	16	7	through	through	IN
work_xuhc2rtekzcknbwcjbro6xyloi	16	8	competition	competition	NN
work_xuhc2rtekzcknbwcjbro6xyloi	16	9	or	or	CC
work_xuhc2rtekzcknbwcjbro6xyloi	16	10	increase	increase	NN
work_xuhc2rtekzcknbwcjbro6xyloi	16	11	in	in	IN
work_xuhc2rtekzcknbwcjbro6xyloi	16	12	drug	drug	NN
work_xuhc2rtekzcknbwcjbro6xyloi	16	13	price	price	NN
work_xuhc2rtekzcknbwcjbro6xyloi	16	14	is	be	VBZ
work_xuhc2rtekzcknbwcjbro6xyloi	16	15	due	due	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	16	16	to	to	TO
work_xuhc2rtekzcknbwcjbro6xyloi	16	17	increase	increase	VB
work_xuhc2rtekzcknbwcjbro6xyloi	16	18	in	in	IN
work_xuhc2rtekzcknbwcjbro6xyloi	16	19	DTC	dtc	NN
work_xuhc2rtekzcknbwcjbro6xyloi	16	20	advertising	advertising	NN
work_xuhc2rtekzcknbwcjbro6xyloi	16	21	spending	spending	NN
work_xuhc2rtekzcknbwcjbro6xyloi	16	22	.	.	.
work_xuhc2rtekzcknbwcjbro6xyloi	17	1	HP7	HP7	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	17	2	IMPACT	IMPACT	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	17	3	OF	of	IN
work_xuhc2rtekzcknbwcjbro6xyloi	17	4	DIRECT	DIRECT	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	17	5	TO	to	IN
work_xuhc2rtekzcknbwcjbro6xyloi	17	6	CONSUMER	consumer	NN
work_xuhc2rtekzcknbwcjbro6xyloi	17	7	ADVERTISING	advertising	NN
work_xuhc2rtekzcknbwcjbro6xyloi	17	8	—	—	:
work_xuhc2rtekzcknbwcjbro6xyloi	17	9	THE	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	17	10	CONSUMER	consumer	NN
work_xuhc2rtekzcknbwcjbro6xyloi	17	11	SEARCH	SEARCH	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	17	12	FOR	for	IN
work_xuhc2rtekzcknbwcjbro6xyloi	17	13	INFORMATION	INFORMATION	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	17	14	Belazi	Belazi	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	17	15	DT1	DT1	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	17	16	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	17	17	Crawford	Crawford	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	17	18	A2	A2	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	17	19	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	17	20	Pizzi	Pizzi	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	17	21	L2	L2	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	17	22	1Thomas	1Thomas	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	17	23	Jefferson	Jefferson	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	17	24	University	University	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	17	25	&	&	CC
work_xuhc2rtekzcknbwcjbro6xyloi	17	26	Abbott	Abbott	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	17	27	Laboratories	Laboratories	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	17	28	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	17	29	Philadelphia	Philadelphia	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	17	30	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	17	31	PA	PA	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	17	32	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	17	33	USA	USA	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	17	34	;	;	:
work_xuhc2rtekzcknbwcjbro6xyloi	17	35	2Thomas	2thomas	CD
work_xuhc2rtekzcknbwcjbro6xyloi	17	36	Jefferson	Jefferson	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	17	37	University	University	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	17	38	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	17	39	Philadelphia	Philadelphia	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	17	40	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	17	41	PA	PA	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	17	42	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	17	43	USA	USA	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	17	44	OBJECTIVE	OBJECTIVE	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	17	45	:	:	:
work_xuhc2rtekzcknbwcjbro6xyloi	17	46	The	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	17	47	purpose	purpose	NN
work_xuhc2rtekzcknbwcjbro6xyloi	17	48	of	of	IN
work_xuhc2rtekzcknbwcjbro6xyloi	17	49	this	this	DT
work_xuhc2rtekzcknbwcjbro6xyloi	17	50	study	study	NN
work_xuhc2rtekzcknbwcjbro6xyloi	17	51	is	be	VBZ
work_xuhc2rtekzcknbwcjbro6xyloi	17	52	to	to	TO
work_xuhc2rtekzcknbwcjbro6xyloi	17	53	identify	identify	VB
work_xuhc2rtekzcknbwcjbro6xyloi	17	54	factors	factor	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	17	55	associated	associate	VBN
work_xuhc2rtekzcknbwcjbro6xyloi	17	56	with	with	IN
work_xuhc2rtekzcknbwcjbro6xyloi	17	57	consumers	consumer	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	17	58	’	’	POS
work_xuhc2rtekzcknbwcjbro6xyloi	17	59	seeking	seek	VBG
work_xuhc2rtekzcknbwcjbro6xyloi	17	60	various	various	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	17	61	infor-	infor-	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	17	62	mation	mation	NN
work_xuhc2rtekzcknbwcjbro6xyloi	17	63	sources	source	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	17	64	about	about	IN
work_xuhc2rtekzcknbwcjbro6xyloi	17	65	medications	medication	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	17	66	sought	seek	VBN
work_xuhc2rtekzcknbwcjbro6xyloi	17	67	in	in	IN
work_xuhc2rtekzcknbwcjbro6xyloi	17	68	response	response	NN
work_xuhc2rtekzcknbwcjbro6xyloi	17	69	to	to	TO
work_xuhc2rtekzcknbwcjbro6xyloi	17	70	direct	direct	VB
work_xuhc2rtekzcknbwcjbro6xyloi	17	71	to	to	IN
work_xuhc2rtekzcknbwcjbro6xyloi	17	72	consumer	consumer	NN
work_xuhc2rtekzcknbwcjbro6xyloi	17	73	advertising	advertising	NN
work_xuhc2rtekzcknbwcjbro6xyloi	17	74	.	.	.
work_xuhc2rtekzcknbwcjbro6xyloi	18	1	METHODS	METHODS	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	18	2	:	:	:
work_xuhc2rtekzcknbwcjbro6xyloi	18	3	In	in	IN
work_xuhc2rtekzcknbwcjbro6xyloi	18	4	the	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	18	5	spring	spring	NN
work_xuhc2rtekzcknbwcjbro6xyloi	18	6	and	and	CC
work_xuhc2rtekzcknbwcjbro6xyloi	18	7	summer	summer	NN
work_xuhc2rtekzcknbwcjbro6xyloi	18	8	of	of	IN
work_xuhc2rtekzcknbwcjbro6xyloi	18	9	1999	1999	CD
work_xuhc2rtekzcknbwcjbro6xyloi	18	10	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	18	11	the	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	18	12	FDA	FDA	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	18	13	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	18	14	Division	Division	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	18	15	of	of	IN
work_xuhc2rtekzcknbwcjbro6xyloi	18	16	Drug	Drug	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	18	17	Marketing	Marketing	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	18	18	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	18	19	Advertising	advertising	NN
work_xuhc2rtekzcknbwcjbro6xyloi	18	20	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	18	21	and	and	CC
work_xuhc2rtekzcknbwcjbro6xyloi	18	22	Commu-	Commu-	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	18	23	nication	nication	NN
work_xuhc2rtekzcknbwcjbro6xyloi	18	24	conducted	conduct	VBD
work_xuhc2rtekzcknbwcjbro6xyloi	18	25	a	a	DT
work_xuhc2rtekzcknbwcjbro6xyloi	18	26	national	national	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	18	27	telephone	telephone	NN
work_xuhc2rtekzcknbwcjbro6xyloi	18	28	survey	survey	NN
work_xuhc2rtekzcknbwcjbro6xyloi	18	29	of	of	IN
work_xuhc2rtekzcknbwcjbro6xyloi	18	30	adults	adult	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	18	31	regarding	regard	VBG
work_xuhc2rtekzcknbwcjbro6xyloi	18	32	Direct	Direct	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	18	33	-	-	HYPH
work_xuhc2rtekzcknbwcjbro6xyloi	18	34	to	to	IN
work_xuhc2rtekzcknbwcjbro6xyloi	18	35	-	-	HYPH
work_xuhc2rtekzcknbwcjbro6xyloi	18	36	Consumer	Consumer	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	18	37	(	(	-LRB-
work_xuhc2rtekzcknbwcjbro6xyloi	18	38	DTC	DTC	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	18	39	)	)	-RRB-
work_xuhc2rtekzcknbwcjbro6xyloi	18	40	promotion	promotion	NN
work_xuhc2rtekzcknbwcjbro6xyloi	18	41	of	of	IN
work_xuhc2rtekzcknbwcjbro6xyloi	18	42	prescription	prescription	NN
work_xuhc2rtekzcknbwcjbro6xyloi	18	43	drugs	drug	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	18	44	and	and	CC
work_xuhc2rtekzcknbwcjbro6xyloi	18	45	its	-PRON-	PRP$
work_xuhc2rtekzcknbwcjbro6xyloi	18	46	effects	effect	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	18	47	on	on	IN
work_xuhc2rtekzcknbwcjbro6xyloi	18	48	visits	visit	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	18	49	to	to	IN
work_xuhc2rtekzcknbwcjbro6xyloi	18	50	the	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	18	51	doctor	doctor	NN
work_xuhc2rtekzcknbwcjbro6xyloi	18	52	.	.	.
work_xuhc2rtekzcknbwcjbro6xyloi	19	1	In	in	IN
work_xuhc2rtekzcknbwcjbro6xyloi	19	2	addition	addition	NN
work_xuhc2rtekzcknbwcjbro6xyloi	19	3	to	to	IN
work_xuhc2rtekzcknbwcjbro6xyloi	19	4	consumer	consumer	NN
work_xuhc2rtekzcknbwcjbro6xyloi	19	5	attitudes	attitude	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	19	6	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	19	7	opinions	opinion	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	19	8	and	and	CC
work_xuhc2rtekzcknbwcjbro6xyloi	19	9	responses	response	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	19	10	to	to	TO
work_xuhc2rtekzcknbwcjbro6xyloi	19	11	direct	direct	VB
work_xuhc2rtekzcknbwcjbro6xyloi	19	12	to	to	IN
work_xuhc2rtekzcknbwcjbro6xyloi	19	13	consumer	consumer	NN
work_xuhc2rtekzcknbwcjbro6xyloi	19	14	advertising	advertising	NN
work_xuhc2rtekzcknbwcjbro6xyloi	19	15	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	19	16	the	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	19	17	survey	survey	NN
work_xuhc2rtekzcknbwcjbro6xyloi	19	18	also	also	RB
work_xuhc2rtekzcknbwcjbro6xyloi	19	19	elicited	elicit	VBD
work_xuhc2rtekzcknbwcjbro6xyloi	19	20	responses	response	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	19	21	regarding	regard	VBG
work_xuhc2rtekzcknbwcjbro6xyloi	19	22	consumer	consumer	NN
work_xuhc2rtekzcknbwcjbro6xyloi	19	23	utilization	utilization	NN
work_xuhc2rtekzcknbwcjbro6xyloi	19	24	of	of	IN
work_xuhc2rtekzcknbwcjbro6xyloi	19	25	information	information	NN
work_xuhc2rtekzcknbwcjbro6xyloi	19	26	sources	source	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	19	27	such	such	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	19	28	as	as	IN
work_xuhc2rtekzcknbwcjbro6xyloi	19	29	reference	reference	NN
work_xuhc2rtekzcknbwcjbro6xyloi	19	30	books	book	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	19	31	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	19	32	800-telelphone	800-telelphone	CD
work_xuhc2rtekzcknbwcjbro6xyloi	19	33	number	number	NN
work_xuhc2rtekzcknbwcjbro6xyloi	19	34	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	19	35	and	and	CC
work_xuhc2rtekzcknbwcjbro6xyloi	19	36	health	health	NN
work_xuhc2rtekzcknbwcjbro6xyloi	19	37	care	care	NN
work_xuhc2rtekzcknbwcjbro6xyloi	19	38	providers	provider	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	19	39	.	.	.
work_xuhc2rtekzcknbwcjbro6xyloi	20	1	There	there	EX
work_xuhc2rtekzcknbwcjbro6xyloi	20	2	were	be	VBD
work_xuhc2rtekzcknbwcjbro6xyloi	20	3	1081	1081	CD
work_xuhc2rtekzcknbwcjbro6xyloi	20	4	total	total	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	20	5	respon-	respon-	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	20	6	dents	dent	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	20	7	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	20	8	of	of	IN
work_xuhc2rtekzcknbwcjbro6xyloi	20	9	whom	whom	WP
work_xuhc2rtekzcknbwcjbro6xyloi	20	10	769	769	CD
work_xuhc2rtekzcknbwcjbro6xyloi	20	11	completed	complete	VBD
work_xuhc2rtekzcknbwcjbro6xyloi	20	12	the	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	20	13	required	require	VBN
work_xuhc2rtekzcknbwcjbro6xyloi	20	14	questions	question	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	20	15	regarding	regard	VBG
work_xuhc2rtekzcknbwcjbro6xyloi	20	16	information	information	NN
work_xuhc2rtekzcknbwcjbro6xyloi	20	17	sources	source	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	20	18	.	.	.
work_xuhc2rtekzcknbwcjbro6xyloi	21	1	Chi	Chi	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	21	2	Square	Square	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	21	3	analysis	analysis	NN
work_xuhc2rtekzcknbwcjbro6xyloi	21	4	was	be	VBD
work_xuhc2rtekzcknbwcjbro6xyloi	21	5	used	use	VBN
work_xuhc2rtekzcknbwcjbro6xyloi	21	6	to	to	TO
work_xuhc2rtekzcknbwcjbro6xyloi	21	7	assess	assess	VB
work_xuhc2rtekzcknbwcjbro6xyloi	21	8	associations	association	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	21	9	between	between	IN
work_xuhc2rtekzcknbwcjbro6xyloi	21	10	consumer	consumer	NN
work_xuhc2rtekzcknbwcjbro6xyloi	21	11	demographic	demographic	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	21	12	information	information	NN
work_xuhc2rtekzcknbwcjbro6xyloi	21	13	and	and	CC
work_xuhc2rtekzcknbwcjbro6xyloi	21	14	the	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	21	15	different	different	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	21	16	types	type	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	21	17	of	of	IN
work_xuhc2rtekzcknbwcjbro6xyloi	21	18	informational	informational	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	21	19	resources	resource	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	21	20	that	that	WDT
work_xuhc2rtekzcknbwcjbro6xyloi	21	21	consumers	consumer	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	21	22	used	use	VBN
work_xuhc2rtekzcknbwcjbro6xyloi	21	23	after	after	IN
work_xuhc2rtekzcknbwcjbro6xyloi	21	24	exposure	exposure	NN
work_xuhc2rtekzcknbwcjbro6xyloi	21	25	of	of	IN
work_xuhc2rtekzcknbwcjbro6xyloi	21	26	direct	direct	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	21	27	to	to	IN
work_xuhc2rtekzcknbwcjbro6xyloi	21	28	consumer	consumer	NN
work_xuhc2rtekzcknbwcjbro6xyloi	21	29	advertising	advertising	NN
work_xuhc2rtekzcknbwcjbro6xyloi	21	30	.	.	.
work_xuhc2rtekzcknbwcjbro6xyloi	22	1	RESULTS	RESULTS	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	22	2	:	:	:
work_xuhc2rtekzcknbwcjbro6xyloi	22	3	The	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	22	4	analysis	analysis	NN
work_xuhc2rtekzcknbwcjbro6xyloi	22	5	showed	show	VBD
work_xuhc2rtekzcknbwcjbro6xyloi	22	6	significant	significant	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	22	7	associations	association	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	22	8	(	(	-LRB-
work_xuhc2rtekzcknbwcjbro6xyloi	22	9	p	p	DT
work_xuhc2rtekzcknbwcjbro6xyloi	22	10	£	£	$
work_xuhc2rtekzcknbwcjbro6xyloi	22	11	0.05	0.05	CD
work_xuhc2rtekzcknbwcjbro6xyloi	22	12	)	)	-RRB-
work_xuhc2rtekzcknbwcjbro6xyloi	22	13	between	between	IN
work_xuhc2rtekzcknbwcjbro6xyloi	22	14	gender	gender	NN
work_xuhc2rtekzcknbwcjbro6xyloi	22	15	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	22	16	race	race	NN
work_xuhc2rtekzcknbwcjbro6xyloi	22	17	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	22	18	education	education	NN
work_xuhc2rtekzcknbwcjbro6xyloi	22	19	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	22	20	health	health	NN
work_xuhc2rtekzcknbwcjbro6xyloi	22	21	status	status	NN
work_xuhc2rtekzcknbwcjbro6xyloi	22	22	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	22	23	self	self	NN
work_xuhc2rtekzcknbwcjbro6xyloi	22	24	-	-	HYPH
work_xuhc2rtekzcknbwcjbro6xyloi	22	25	perceived	perceive	VBN
work_xuhc2rtekzcknbwcjbro6xyloi	22	26	knowledge	knowledge	NN
work_xuhc2rtekzcknbwcjbro6xyloi	22	27	of	of	IN
work_xuhc2rtekzcknbwcjbro6xyloi	22	28	health	health	NN
work_xuhc2rtekzcknbwcjbro6xyloi	22	29	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	22	30	prescription	prescription	NN
work_xuhc2rtekzcknbwcjbro6xyloi	22	31	medication	medication	NN
work_xuhc2rtekzcknbwcjbro6xyloi	22	32	use	use	NN
work_xuhc2rtekzcknbwcjbro6xyloi	22	33	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	22	34	and	and	CC
work_xuhc2rtekzcknbwcjbro6xyloi	22	35	internet	internet	NN
work_xuhc2rtekzcknbwcjbro6xyloi	22	36	use	use	NN
work_xuhc2rtekzcknbwcjbro6xyloi	22	37	and	and	CC
work_xuhc2rtekzcknbwcjbro6xyloi	22	38	many	many	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	22	39	of	of	IN
work_xuhc2rtekzcknbwcjbro6xyloi	22	40	the	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	22	41	following	follow	VBG
work_xuhc2rtekzcknbwcjbro6xyloi	22	42	information	information	NN
work_xuhc2rtekzcknbwcjbro6xyloi	22	43	resources	resource	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	22	44	:	:	:
work_xuhc2rtekzcknbwcjbro6xyloi	22	45	reference	reference	NN
work_xuhc2rtekzcknbwcjbro6xyloi	22	46	books	book	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	22	47	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	22	48	asking	ask	VBG
work_xuhc2rtekzcknbwcjbro6xyloi	22	49	friends	friend	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	22	50	/	/	SYM
work_xuhc2rtekzcknbwcjbro6xyloi	22	51	neighbors	neighbor	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	22	52	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	22	53	800-telephone	800-telephone	CD
work_xuhc2rtekzcknbwcjbro6xyloi	22	54	number	number	NN
work_xuhc2rtekzcknbwcjbro6xyloi	22	55	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	22	56	primary	primary	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	22	57	doctor	doctor	NN
work_xuhc2rtekzcknbwcjbro6xyloi	22	58	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	22	59	pharmacist	pharmacist	NN
work_xuhc2rtekzcknbwcjbro6xyloi	22	60	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	22	61	specialist	specialist	NN
work_xuhc2rtekzcknbwcjbro6xyloi	22	62	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	22	63	and	and	CC
work_xuhc2rtekzcknbwcjbro6xyloi	22	64	nurse	nurse	NN
work_xuhc2rtekzcknbwcjbro6xyloi	22	65	.	.	.
work_xuhc2rtekzcknbwcjbro6xyloi	23	1	Across	across	IN
work_xuhc2rtekzcknbwcjbro6xyloi	23	2	all	all	DT
work_xuhc2rtekzcknbwcjbro6xyloi	23	3	information	information	NN
work_xuhc2rtekzcknbwcjbro6xyloi	23	4	sources	source	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	23	5	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	23	6	female	female	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	23	7	gender	gender	NN
work_xuhc2rtekzcknbwcjbro6xyloi	23	8	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	23	9	decreased	decrease	VBD
work_xuhc2rtekzcknbwcjbro6xyloi	23	10	health	health	NN
work_xuhc2rtekzcknbwcjbro6xyloi	23	11	status	status	NN
work_xuhc2rtekzcknbwcjbro6xyloi	23	12	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	23	13	low	low	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	23	14	education	education	NN
work_xuhc2rtekzcknbwcjbro6xyloi	23	15	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	23	16	and	and	CC
work_xuhc2rtekzcknbwcjbro6xyloi	23	17	higher	high	JJR
work_xuhc2rtekzcknbwcjbro6xyloi	23	18	than	than	IN
work_xuhc2rtekzcknbwcjbro6xyloi	23	19	average	average	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	23	20	medica-	medica-	NN
work_xuhc2rtekzcknbwcjbro6xyloi	23	21	tion	tion	NN
work_xuhc2rtekzcknbwcjbro6xyloi	23	22	use	use	NN
work_xuhc2rtekzcknbwcjbro6xyloi	23	23	were	be	VBD
work_xuhc2rtekzcknbwcjbro6xyloi	23	24	the	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	23	25	variables	variable	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	23	26	that	that	WDT
work_xuhc2rtekzcknbwcjbro6xyloi	23	27	had	have	VBD
work_xuhc2rtekzcknbwcjbro6xyloi	23	28	the	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	23	29	strongest	strong	JJS
work_xuhc2rtekzcknbwcjbro6xyloi	23	30	associ-	associ-	NN
work_xuhc2rtekzcknbwcjbro6xyloi	23	31	ations	ation	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	23	32	.	.	.
work_xuhc2rtekzcknbwcjbro6xyloi	24	1	A	a	DT
work_xuhc2rtekzcknbwcjbro6xyloi	24	2	model	model	NN
work_xuhc2rtekzcknbwcjbro6xyloi	24	3	was	be	VBD
work_xuhc2rtekzcknbwcjbro6xyloi	24	4	developed	develop	VBN
work_xuhc2rtekzcknbwcjbro6xyloi	24	5	depicting	depict	VBG
work_xuhc2rtekzcknbwcjbro6xyloi	24	6	the	the	DT
work_xuhc2rtekzcknbwcjbro6xyloi	24	7	associations	association	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	24	8	between	between	IN
work_xuhc2rtekzcknbwcjbro6xyloi	24	9	these	these	DT
work_xuhc2rtekzcknbwcjbro6xyloi	24	10	findings	finding	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	24	11	.	.	.
work_xuhc2rtekzcknbwcjbro6xyloi	25	1	Results	result	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	25	2	pertaining	pertain	VBG
work_xuhc2rtekzcknbwcjbro6xyloi	25	3	to	to	IN
work_xuhc2rtekzcknbwcjbro6xyloi	25	4	specific	specific	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	25	5	sources	source	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	25	6	will	will	MD
work_xuhc2rtekzcknbwcjbro6xyloi	25	7	be	be	VB
work_xuhc2rtekzcknbwcjbro6xyloi	25	8	presented	present	VBN
work_xuhc2rtekzcknbwcjbro6xyloi	25	9	.	.	.
work_xuhc2rtekzcknbwcjbro6xyloi	26	1	CONCLUSIONS	conclusion	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	26	2	:	:	:
work_xuhc2rtekzcknbwcjbro6xyloi	26	3	This	this	DT
work_xuhc2rtekzcknbwcjbro6xyloi	26	4	study	study	NN
work_xuhc2rtekzcknbwcjbro6xyloi	26	5	evaluated	evaluate	VBD
work_xuhc2rtekzcknbwcjbro6xyloi	26	6	how	how	WRB
work_xuhc2rtekzcknbwcjbro6xyloi	26	7	different	different	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	26	8	consumers	consumer	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	26	9	seek	seek	VBP
work_xuhc2rtekzcknbwcjbro6xyloi	26	10	information	information	NN
work_xuhc2rtekzcknbwcjbro6xyloi	26	11	from	from	IN
work_xuhc2rtekzcknbwcjbro6xyloi	26	12	different	different	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	26	13	sources	source	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	26	14	as	as	IN
work_xuhc2rtekzcknbwcjbro6xyloi	26	15	a	a	DT
work_xuhc2rtekzcknbwcjbro6xyloi	26	16	result	result	NN
work_xuhc2rtekzcknbwcjbro6xyloi	26	17	of	of	IN
work_xuhc2rtekzcknbwcjbro6xyloi	26	18	direct	direct	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	26	19	to	to	IN
work_xuhc2rtekzcknbwcjbro6xyloi	26	20	consumer	consumer	NN
work_xuhc2rtekzcknbwcjbro6xyloi	26	21	advertising	advertising	NN
work_xuhc2rtekzcknbwcjbro6xyloi	26	22	.	.	.
work_xuhc2rtekzcknbwcjbro6xyloi	27	1	This	this	DT
work_xuhc2rtekzcknbwcjbro6xyloi	27	2	study	study	NN
work_xuhc2rtekzcknbwcjbro6xyloi	27	3	will	will	MD
work_xuhc2rtekzcknbwcjbro6xyloi	27	4	assist	assist	VB
work_xuhc2rtekzcknbwcjbro6xyloi	27	5	those	those	DT
work_xuhc2rtekzcknbwcjbro6xyloi	27	6	interested	interested	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	27	7	in	in	IN
work_xuhc2rtekzcknbwcjbro6xyloi	27	8	identifying	identify	VBG
work_xuhc2rtekzcknbwcjbro6xyloi	27	9	and	and	CC
work_xuhc2rtekzcknbwcjbro6xyloi	27	10	further	further	JJ
work_xuhc2rtekzcknbwcjbro6xyloi	27	11	educat-	educat-	NN
work_xuhc2rtekzcknbwcjbro6xyloi	27	12	ing	e	VBG
work_xuhc2rtekzcknbwcjbro6xyloi	27	13	consumers	consumer	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	27	14	about	about	IN
work_xuhc2rtekzcknbwcjbro6xyloi	27	15	their	-PRON-	PRP$
work_xuhc2rtekzcknbwcjbro6xyloi	27	16	health	health	NN
work_xuhc2rtekzcknbwcjbro6xyloi	27	17	and	and	CC
work_xuhc2rtekzcknbwcjbro6xyloi	27	18	novel	novel	NN
work_xuhc2rtekzcknbwcjbro6xyloi	27	19	treatments	treatment	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	27	20	or	or	CC
work_xuhc2rtekzcknbwcjbro6xyloi	27	21	therapies	therapy	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	27	22	.	.	.
work_xuhc2rtekzcknbwcjbro6xyloi	28	1	HP8	HP8	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	28	2	FDA	FDA	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	28	3	REGULATORY	REGULATORY	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	28	4	ACTIONS	actions	NN
work_xuhc2rtekzcknbwcjbro6xyloi	28	5	AGAINST	against	RB
work_xuhc2rtekzcknbwcjbro6xyloi	28	6	MISLEADING	mislead	VBG
work_xuhc2rtekzcknbwcjbro6xyloi	28	7	OR	or	CC
work_xuhc2rtekzcknbwcjbro6xyloi	28	8	UNSUBSTANTIATED	UNSUBSTANTIATED	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	28	9	ECONOMIC	ECONOMIC	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	28	10	AND	and	CC
work_xuhc2rtekzcknbwcjbro6xyloi	28	11	QUALITY	quality	NN
work_xuhc2rtekzcknbwcjbro6xyloi	28	12	-	-	HYPH
work_xuhc2rtekzcknbwcjbro6xyloi	28	13	OF	of	IN
work_xuhc2rtekzcknbwcjbro6xyloi	28	14	-	-	HYPH
work_xuhc2rtekzcknbwcjbro6xyloi	28	15	LIFE	life	NN
work_xuhc2rtekzcknbwcjbro6xyloi	28	16	CLAIMS	claim	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	28	17	:	:	:
work_xuhc2rtekzcknbwcjbro6xyloi	28	18	AN	an	DT
work_xuhc2rtekzcknbwcjbro6xyloi	28	19	ANALYSIS	analysis	NN
work_xuhc2rtekzcknbwcjbro6xyloi	28	20	OF	of	IN
work_xuhc2rtekzcknbwcjbro6xyloi	28	21	WARNING	warning	NN
work_xuhc2rtekzcknbwcjbro6xyloi	28	22	LETTERS	letter	NNS
work_xuhc2rtekzcknbwcjbro6xyloi	28	23	AND	and	CC
work_xuhc2rtekzcknbwcjbro6xyloi	28	24	NOTICES	notices	NN
work_xuhc2rtekzcknbwcjbro6xyloi	28	25	OF	of	IN
work_xuhc2rtekzcknbwcjbro6xyloi	28	26	VIOLATION	VIOLATION	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	28	27	Stewart	Stewart	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	28	28	KA	KA	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	28	29	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	28	30	Neumann	Neumann	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	28	31	PJ	PJ	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	28	32	Harvard	Harvard	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	28	33	School	School	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	28	34	of	of	IN
work_xuhc2rtekzcknbwcjbro6xyloi	28	35	Public	Public	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	28	36	Health	Health	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	28	37	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	28	38	Boston	Boston	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	28	39	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	28	40	MA	MA	NNP
work_xuhc2rtekzcknbwcjbro6xyloi	28	41	,	,	,
work_xuhc2rtekzcknbwcjbro6xyloi	28	42	USA	USA	NNP